{"url":"https://newsforagent.com/news/2026-11-16/ozelle-o-cyte-1-medica-2026-2","markdown_url":"https://newsforagent.com/news/2026-11-16/ozelle-o-cyte-1-medica-2026-2.md","title":"Ozelle Shows O-Cyte 1 Hematology Analyzer at MEDICA 2026","headline":"Ozelle Demonstrates O-Cyte 1 Cell-Imaging Hematology Analyzer at MEDICA 2026 in Düsseldorf","description":"Ozelle is demonstrating O-Cyte 1, an automated hematology analyzer that pairs CBC testing with cell imaging.","section":"Product Launches","published_at":"2026-11-16T10:32:59+00:00","modified_at":"2026-11-16T10:32:59+00:00","author":"News Desk","key_takeaways":["Ozelle is demonstrating O-Cyte 1, an automated hematology analyzer with built-in cell imaging, at MEDICA 2026 in Düsseldorf through November 19.","A standalone O-Cyte 1 processes up to 60 tests per hour, and six connected units reach up to 360 tests per hour.","O-Cyte 1 supports 25-tube batch loading and moves key fluid-contact components into a replaceable reagent kit to reduce cleaning inside the instrument."],"companies":[{"name":"Ozelle","is_primary":true,"profile_url":"https://akta.pro/company-profiles/00pxn5h/ozelle","website":"https://www.ozellemed.com"}],"source":{"publisher":"PR Newswire","title":"From CBC Results to Cell Images: Ozelle Demonstrates O-Cyte 1 at MEDICA 2026","url":"https://www.prnewswire.com/news-releases/from-cbc-results-to-cell-images-ozelle-demonstrates-o-cyte-1-at-medica-2026-302940024.html"},"other_sources":[],"tags":["Product Launches","Ozelle"],"body_markdown":"Ozelle is demonstrating O-Cyte 1, an automated hematology analyzer that combines complete blood count testing with high-resolution cell imaging, at MEDICA 2026 in Düsseldorf. The company announced the demonstration in a [PR Newswire](https://www.prnewswire.com/news-releases/from-cbc-results-to-cell-images-ozelle-demonstrates-o-cyte-1-at-medica-2026-302940024.html) release on November 16, 2026.\n\n## How O-Cyte 1 Handles CBC and Cell Imaging\n\n[Ozelle](https://akta.pro/company-profiles/00pxn5h/ozelle) built O-Cyte 1 around its AI × CBM (Complete Blood Morphology) technology, which pairs cell imaging with AI-assisted morphology analysis. The analyzer integrates that capability with 7-part white blood cell differentiation. Cell images captured during automated testing are available alongside CBC results for laboratory professionals to review when further morphology assessment is needed.\n\nO-Cyte 1 supports 25-tube batch loading, automated barcode identification and mixing, closed-tube sampling and STAT priority, according to akta.pro [company records](https://akta.pro/company-data). A standalone analyzer processes up to 60 tests per hour, while six connected units reach up to 360 tests per hour, allowing laboratories to expand capacity as workloads grow.\n\nOn maintenance, Ozelle says conventional analyzers with reusable internal fluid paths require regular cleaning. O-Cyte 1 instead integrates key fluid-contact components into a replaceable reagent kit, which the company says helps reduce cleaning inside the instrument. Built-in self-checks and replaceable modules support troubleshooting and servicing, including after-sales support for distributors.\n\n\"We wanted to make cell morphology part of routine CBC testing while keeping laboratory workflows efficient,\" said Jie Du, Co-founder and Head of R&D at Ozelle. \"That meant designing the entire system with sample handling, image review and maintenance in mind.\"\n\nOzelle is also showing its compact EHBT analyzer series for human care, covering hematology, cell imaging, immunoassay and dry biochemistry, and its EHVT veterinary series, which offers hematology, digital cell morphology, immunoassay, biochemistry, urine and fecal testing. Live demonstrations run through November 19 at Hall 1, Booth D63, Messe Düsseldorf.\n\n## Ozelle's Earlier O-Cyte 1 Rollout\n\nOzelle announced on October 28, 2026, that it would spotlight O-Cyte 1 at MEDICA 2026, describing standalone throughput of 60 tests per hour and a six-unit cascade up to 360, according to Newswire. The company launched O-Cyte 1 at ADLM 2026 in Anaheim, California, on July 28, 2026, marking its entry into AI-powered hematology with AI × CBM technology, Aijourn reported. Before that, Ozelle said on June 29, 2026, that it would debut the analyzer at ADLM 2026, according to PR Newswire.\n\n## Where to See the Analyzers at MEDICA\n\nVisitors can see the analyzers at work and discuss clinical applications and distribution opportunities at the Ozelle booth during the show, which runs through November 19. The company's [product site](https://www.ozellemed.com) lists its hematology and diagnostic lines.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}